Our new X account is live! Follow @wizwand_team for updates
WorkDL logo mark

EvoEGF-Mol: Evolving Exponential Geodesic Flow for Structure-based Drug Design

About

Structure-Based Drug Design (SBDD) aims to discover bioactive ligands. Conventional approaches construct probability paths separately in Euclidean and probabilistic spaces for continuous atomic coordinates and discrete chemical categories, leading to a mismatch with the underlying statistical manifolds. We address this issue from an information-geometric perspective by modeling molecules as composite exponential-family distributions and defining generative flows along exponential geodesics under the Fisher-Rao metric. To avoid the instantaneous trajectory collapse induced by geodesics directly targeting Dirac distributions, we propose Evolving Exponential Geodesic Flow for SBDD (EvoEGF-Mol), which replaces static Dirac targets with dynamically concentrating distributions, ensuring stable training via a progressive-parameter-refinement architecture. Our model approaches a reference-level PoseBusters passing rate (93.4%) on CrossDock, demonstrating remarkable geometric precision and interaction fidelity, while outperforming baselines on real-world MolGenBench tasks by recovering bioactive scaffolds and generating candidates that meet established MedChem filters.

Yaowei Jin, Junjie Wang, Cheng Cao, Penglei Wang, Duo An, Qian Shi• 2026

Related benchmarks

TaskDatasetResultRank
structure-based drug designMolGenBench Proteins in CrossDock
Pass Rate37.52
10
structure-based drug designMolGenBench In(RM.): Proteins in CrossDock, remove SMILES in CrossDock (train)
Hit Recovery500
10
structure-based drug designMolGenBench Not: Proteins not in CrossDock
Pass Rate33.75
10
structure-based drug designCrossDock 2020 (test)
PB Valid93.4
6
Showing 4 of 4 rows

Other info

Follow for update